Ferreira D, Nordberg A, Westman E (2020) Biological subtypes of Alzheimer’s disease: a systematic review and meta-analysis. Neurology 94:436–448
Article
PubMed
PubMed Central
Google Scholar
Graff-radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC et al (2021) New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol 20:222–234
Article
PubMed
PubMed Central
Google Scholar
Habes M, Grothe MJ, Tunc B, Mcmillan C, Wolk DA, Davatzikos C (2020) Disentangling heterogeneity in Alzheimer’s disease and related dementias using data-driven methods. Biol Psychiatry 88:70–82
Article
PubMed
PubMed Central
Google Scholar
Hanna Al-Shaikh FS, Duara R, Crook JE, Lesser ER, Schaeverbeke J, Hinkle KM et al (2020) Selective vulnerability of the nucleus basalis of meynert among neuropathologic subtypes of alzheimer disease. JAMA Neurol 77:225–233
Article
PubMed
Google Scholar
Jellinger KA (2021) Pathobiological subtypes of alzheimer disease. Dement Geriatr Cogn Disord 49:321–333
Article
Google Scholar
Charil A, Shcherbinin S, Southekal S, Devous MD, Mintun M, Murray ME et al (2019) Tau subtypes of Alzheimer’s disease determined in vivo using flortaucipir PET imaging. J Alzheimer’s Dis 71:1037–1048
Article
CAS
Google Scholar
Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785–796
Article
PubMed
PubMed Central
Google Scholar
Mohanty R, Mårtensson G, Poulakis K, Muehlboeck J-S, Rodriguez-Vieitez E, Chiotis K et al (2020) Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization. Brain Commun 2:192
Article
Google Scholar
Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML et al (2012) Neuroimaging correlates of pathologically defined subtypes of Alzheimer’s disease: a case-control study. Lancet Neurol 11:868–877
Article
PubMed
PubMed Central
Google Scholar
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
Article
CAS
PubMed
Google Scholar
Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML et al (2018) [18F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer’s disease. Ann Neurol 83:248–257
Article
CAS
PubMed
PubMed Central
Google Scholar
Young CB, Winer JR, Younes K, Cody KA, Betthauser TJ, Johnson SC et al (2022) Divergent cortical tau positron emission tomography patterns among patients with preclinical alzheimer disease. JAMA Neurol 79:592–603
Article
PubMed
Google Scholar
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W et al (2005) The Alzheimer’s disease neuroimaging initiative. Neuroimaging Clin N Am 15:869–877
Article
PubMed
PubMed Central
Google Scholar
Jack CR, Wiste HJ, Botha H, Weigand SD, Therneau TM, Knopman DS et al (2019) The bivariate distribution of amyloid-β and tau: Relationship with established neurocognitive clinical syndromes. Brain 142:3230–3242
Article
PubMed
PubMed Central
Google Scholar
Byun MS, Kim SE, Park J, Yi D, Choe YM, Sohn BK et al (2015) Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer’s disease. PLoS ONE 10:e0142756
Article
PubMed
PubMed Central
Google Scholar
Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS et al (2017) Defining imaging biomarker cut points for brain aging and Alzheimer’s disease. Alzheimer’s Dement 13:205–216
Article
Google Scholar
Tudorascu D, Ikonomovic MD, Burnham S, Minhas D, Pascoal TA, Mason NS et al (2021) What Is T+? A gordian knot of tracers, thresholds, and topographies. J Nucl Med 62:614–619
Article
PubMed
Google Scholar
Schöll M, Lockhart SN, Schonhaut DR, Neil JPO, Ossenkoppele R, Baker SL et al (2016) PET imaging of tau deposition in the aging human brain Michael. Neuron 89:971–982
Article
PubMed
PubMed Central
Google Scholar
Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La R et al (2017) Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer’s disease. Neuroimage 157:448–463
Article
CAS
PubMed
Google Scholar
Risacher SL, Anderson WH, Charil A, Castelluccio PF, Shcherbinin S, Saykin AJ et al (2017) Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline. Neurology 89:2176–2186
Article
PubMed
PubMed Central
Google Scholar
Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E et al (2019) Tau PET imaging in neurodegenerative tauopathies—still a challenge. Mol Psychiatry 24:1112–1134
Article
CAS
PubMed
PubMed Central
Google Scholar
Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT et al (2021) Four distinct trajectories of tau deposition identified in Alzheimer’s disease. Nat Med 27:871–881
Article
CAS
PubMed
PubMed Central
Google Scholar
Muehlboeck J-S, Westman E, Simmons A (2014) TheHiveDB image data management and analysis framework. Front Neuroinform 7:49
Article
PubMed
PubMed Central
Google Scholar
Sahoo A, Bejanin A, Murray ME, Tosakulwong N, Weigand SD, Serie AM et al (2018) TDP-43 and Alzheimer’s disease pathologic subtype in non-amnestic Alzheimer’s disease dementia. J Alzheimer’s Dis 64:1227–1233
Article
Google Scholar
Petersen C, Nolan AL, de Paula-França-Resende E, Miller Z, Ehrenberg AJ, Gorno-Tempini ML et al (2019) Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Acta Neuropathol 138:597–612
Article
CAS
PubMed
PubMed Central
Google Scholar
Uretsky M, Gibbons LE, Mukherjee S, Trittschuh EH, Fardo DW, Boyle PA et al (2021) Longitudinal cognitive performance of Alzheimer’s disease neuropathological subtypes. Alzheimer’s Dement Transl Res Clin Interv 7:1–13
Google Scholar
Smirnov DS, Salmon DP, Galasko D, Goodwill VS, Hansen LA, Zhao Y et al (2022) Association of neurofibrillary tangle distribution with age at onset-related clinical heterogeneity in Alzheimer disease. Neurology 98:E506-517
Article
CAS
PubMed
Google Scholar
Corder EH, Woodbury MA, Volkmann I, Madsen DK, Bogdanovic N, Winblad B (2000) Density profiles of Alzheimer disease regional brain pathology for the Huddinge brain bank: Pattern recognition emulates and expands upon Braak staging. Exp Gerontol 35:851–864
Article
CAS
PubMed
Google Scholar
Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M et al (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139:1539–1550
Article
PubMed
Google Scholar
Schwarz AJ, Shcherbinin S, Slieker LJ, Risacher SL, Charil A, Irizarry MC et al (2018) Topographic staging of tau positron emission tomography images. Alzheimer’s Dement Diagnosis Assess Dis Monit 10:221–231
Google Scholar
Toledo JB, Liu H, Grothe MJ, Rashid T, Launer L et al (2022) Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer’s disease continuum. Alzheimer’s Dement 8:1–14
Google Scholar
Palleis C, Brendel M, Finze A, Weidinger E, Bötzel K, Danek A et al (2021) Cortical [18F]PI-2620 binding differentiates corticobasal syndrome subtypes. Mov Disord 36:2104–2115
Article
CAS
PubMed
Google Scholar
Rullmann M, Brendel M, Schroeter M, Saur D, Levin J, Perneczky R et al (2022) Multicenter F-18-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer’s disease. Biomolecules 12:458
Article
CAS
PubMed
PubMed Central
Google Scholar
Krishnadas N, Huang K, Schultz SA, Doré V, Bourgeat P, Goh AMY et al (2022) Visually identified Tau 18F-MK6240 PET patterns in symptomatic Alzheimer’s disease. J Alzheimers Dis 88:1627–1637
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferreira D (2020) A conceptual framework for future studies on subtypes of Alzheimer’s disease. Alzheimer’s Dement 16(Suppl.4): e037181. https://doi.org/10.1002/alz.037181
Article
Google Scholar
Franzmeier N, Dewenter A, Frontzkowski L, Dichgans M, Rubinski A, Neitzel J, et al (2020) Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease. Sci Adv 6:eabd1327
Moloney CM, Lowe VJ, Murray ME (2021) Visualization of neurofibrillary tangle maturity in Alzheimer’s disease: a clinicopathologic perspective for biomarker research. Alzheimer’s Dement 17:1554–1574
Article
CAS
Google Scholar
Braak H, Del Tredici K (2015) The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain 138:2814–2833
Article
PubMed
Google Scholar
Westman E, Aguilar C, Muehlboeck JS, Simmons A (2013) Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer’s disease and mild cognitive impairment. Brain Topogr 26:9–23
Article
PubMed
Google Scholar
Mårtensson G, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I et al (2018) Stability of graph theoretical measures in structural brain networks in Alzheimer’s disease. Sci Rep 8:11592
Article
PubMed
PubMed Central
Google Scholar
Ferreira D, Hansson O, Barroso J, Molina Y, Machado A, Hernández-Cabrera JA et al (2017) The interactive effect of demographic and clinical factors on hippocampal volume: a multicohort study on 1958 cognitively normal individuals. Hippocampus 27:653–667
Article
PubMed
Google Scholar
Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG et al (2017) AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81:58–67
Article
CAS
PubMed
Google Scholar
Nedelska Z, Josephs KA, Graff-Radford J, Przybelski SA, Lesnick TG, Boeve BF et al (2019) 18 F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy. Mov Disord 34:344–352
Article
PubMed
PubMed Central
Google Scholar
Smith R, Schöll M, Londos E, Ohlsson T, Hansson O (2018) 18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies. Sci Rep 8:4717
Article
PubMed
PubMed Central
Google Scholar
Gomperts S (2016) Tau PET imaging in the Lewy body diseases. JAMA Neurol 73:1334–1341
Article
PubMed
PubMed Central
Google Scholar
Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS et al (2018) Distinct patterns of amyloid-dependent tau accumulation in lewy body diseases. Mov Disord 33:262–272
Article
CAS
PubMed
Google Scholar
Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K et al (2020) Multimodal in vivo and postmortem assessments of tau in Lewy body disorders. Neurobiol Aging 96:137–147
Article
CAS
PubMed
PubMed Central
Google Scholar
McKeith I, Dickson DW, Lowe J, Halliday G, Taylor J-P, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth report of the DLB Consortium. Neurology 65:1863–1872
Article
Google Scholar
Sarro L, Tosakulwong N, Schwarz CG, Graff-Radford J, Przybelski SA, Lesnick TG et al (2017) An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer’s disease. Alzheimer’s Dement 13:257–266
Article
Google Scholar
Gungor I, Sarro L, Graff-Radford J, Zuk SM, Tosakulwong N, Przybelski SA et al (2015) Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer’s disease. Park Relat Disord 21:1101–1104
Article
Google Scholar
Nedelska Z, Schwarz CG, Boeve BF, Lowe VJ, Reid RI, Przybelski SA et al (2015) White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging. Neurobiol Aging 36:2010–2017
Article
PubMed
PubMed Central
Google Scholar
Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF et al (2018) Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: associations with clinical severity, glucose metabolism and tau PET. NeuroImage Clin 19:939–947
Article
PubMed
PubMed Central
Google Scholar
Oppedal K, Ferreira D, Cavallin L, Lemstra A, ten Kate M, Padovani A et al (2019) A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from The European DLB Consortium. Alzheimer’s Dement 15:400–409
Article
Google Scholar
Jellinger KA (2012) Neuropathological subtypes of Alzheimer’s disease. Acta Neuropathol 123:153–154
Article
PubMed
Google Scholar
Josephs KA, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Liesinger AM et al (2015) TAR DNA-binding protein 43 and pathological subtype of Alzheimer’s disease impact clinical features. Ann Neurol 78:697–709
Article
CAS
PubMed
PubMed Central
Google Scholar
Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L et al (2020) The cholinergic system and treatment response in subtypes of Alzheimer’s disease. Alzheimers Res Ther 12:51
Article
CAS
PubMed
PubMed Central
Google Scholar
Connelly P, Prentice N, Fowler K (2005) Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:320–324
Article
CAS
PubMed
PubMed Central
Google Scholar
McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R et al (2000) Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet 356:2031–2036
Article
CAS
PubMed
Google Scholar
Kantarci K, Petersen RC, Knopman DS, Przybelski S, Lesnick TG, Senjem ML et al (2012) Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. Brain 135:2470–2477
Article
PubMed
PubMed Central
Google Scholar
Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R et al (2012) Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124:681–692
Article
PubMed
PubMed Central
Google Scholar
Yu L, Boyle PA, Dawe RJ, Bennett DA, Arfanakis K, Schneider JA (2020) Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology 94:e142-152
Article
PubMed
PubMed Central
Google Scholar
Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T et al (2018) The contribution of small vessel disease to subtypes of Alzheimer’s disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiol Aging 70:18–29
Article
CAS
PubMed
Google Scholar
Mohanty R, Ferreira D, Nordberg A, Westman E (2021) Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum. medRxiv. https://doi.org/10.1101/2021.08.10.21261824v1
Mohanty R, Ferreira D, Frerich S, Muehlboeck J-S, Grothe MJ, Westman E (2022) Neuropathologic features of antemortem atrophy-based subtypes of Alzheimer disease. Neurology 99:e323–e333
Article
CAS
PubMed Central
Google Scholar
Ossenkoppele R, Hyoung C, Sudre CH, Van WD, Cho H, Hoon Y et al (2020) Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease. Alzheimers Dement 16:335–344
Article
PubMed
PubMed Central
Google Scholar
Poulakis K, Pereira J, Muehlboeck J-S, Wahlund L-O, Smedby Ö, Volpe G et al (2022) Stage vs. Subtype hypothesis in Alzheimer’s disease: a multi-cohort and longitudinal Bayesian clustering study. Nat Commun 13:4566
Article
CAS
PubMed
PubMed Central
Google Scholar
Pascoal TA, Therriault J, Benedet AL, Savard M, Lussier FZ, Chamoun M et al (2020) 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain 143:2818–2830
Article
PubMed
Google Scholar
Colato E, Chiotis K, Ferreira D, Mazrina MS, Lemoine L, Mohanty R et al (2021) Assessment of tau pathology as measured by 18F-THK5317 and 18F-flortaucipir PET and their relation to brain atrophy and cognition in Alzheimer’s disease. J Alzheimer’s Dis 84:103–117
Article
CAS
Google Scholar
Leuzy A, Pascoal TA, Strandberg O, Insel P, Smith R, Mattsson-Carlgren N et al (2021) A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging 48:2295–2305
Article
CAS
PubMed
PubMed Central
Google Scholar
Arendt T, Brückner MK, Morawski M, Jäger C, Gertz H-J (2015) Early neurone loss in Alzheimer’s disease: cortical or subcortical? Acta Neuropathol Commun 3:101–111
Article
Google Scholar
Matchett BJ, Grinberg LT, Theofilas P, Murray ME (2021) The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease. Acta Neuropathol 141:631–650
Article
PubMed
PubMed Central
Google Scholar
Vogel JW, Iturria-Medina Y, Strandberg OT, Smith R, Levitis E, Evans AC et al (2020) Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease. Nat Commun 11:2612
Article
CAS
PubMed
PubMed Central
Google Scholar
Armstrong RA, Nochlin D, Bird TD (2000) Neuropathological heterogeneity in Alzheimer’s disease: a study of 80 cases using principal components analysis. Neuropathology 20:31–37
Article
CAS
PubMed
Google Scholar
Armstrong RA, Wood L, Myers D, Smith CUM (1996) The use of multivariate methods in the identification of subtypes of alzheimer’s disease: a comparison of principal components and cluster analysis. Dement Geriatr Cogn Disord 7:215–220
Article
CAS
Google Scholar
Armstrong RA, Wood L (1994) The identification of pathological subtypes of Alzheimer’s disease using cluster analysis. Acta Neuropathol 88:60–66
Article
CAS
PubMed
Google Scholar
Armstrong RA, Myers D (1992) Principal components analysis of Alzheimer’s disease based on neuropathological data: a study of 79 patients. Neurosci Res Commun 11:1–9
Google Scholar
Blennerhassett R, Lillo P, Halliday GM, Hodges JR (2014) Distribution of pathology in frontal variant Alzheimer’s disease. J Alzheimers Dis 39:63–70
Article
CAS
PubMed
Google Scholar
Bondareff W et al (1993) Evidence of subtypes of Alzheimer’s disease and implications for etiology. Arch Gen Psychiatry 50:350–356
Article
CAS
PubMed
Google Scholar
Coleman PD, Kazee AM, Lapham L, Eskin T, Rogers K (1992) Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer’s disease. Neurobiol Aging 13:631–639
Article
CAS
PubMed
Google Scholar
Cupidi C, Capobianco R, Goffredo D, Marcon G, Ghetti B (2010) Neocortical variation of Aβ load in fully expressed, pure Alzheimer’s disease. J Alzheimers Dis 19:57–68
Article
PubMed
Google Scholar
Das SR et al (2021) Tau-atrophy variability reveals phenotypic heterogeneity in Alzheimer’s disease. Ann Neurol 90:751–762
Article
CAS
PubMed
PubMed Central
Google Scholar
Dugger BN et al (2014) Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. J Neuropathol Exp Neurol 73:72–80
Article
PubMed
Google Scholar
Holzer M, Zedlick D, Bruckner MK (1994) Abnormally phosphorylated tau protein in Alzheimer’s disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63:499–516
Article
CAS
PubMed
Google Scholar
Jeon S et al (2019) Topographical heterogeneity of Alzheimer’s disease based on MR imaging, tau PET, and amyloid PET. Front Aging Neurosci 11:211
Article
CAS
PubMed
PubMed Central
Google Scholar
Kovacs GG (2012) Clinical stratification of subtypes of Alzheimer’s disease. Lancet Neurol 11:839–841
Article
PubMed
Google Scholar
Krishnadas N et al (2022) Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases. Alzheimers Dement (Amst) 14:e12326
Google Scholar
Lowe VJ et al (2018) Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia. Brain 141:271–287
Article
PubMed
Google Scholar
Mizuno Y, Ikeda K, Tsuchiya K, Ishihara R, Shibayama H (2003) Two distinct subgroups of senile dementia of Alzheimer type: quantitative study of neurofibrillary tangles. Neuropathology 23:282–289
Article
PubMed
Google Scholar
Mizutani T (1994) Neuropathological diagnosis of senile dementia of the Alzheimer type (SDAT): proposal of diagnostic criteria and report of the Japanese Research Meeting on Neuropathological Diagnosis of SDAT. Neuropathology 14:91–103
Article
Google Scholar
Oh M et al (2022) [18F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings. J Clin Neurol 18:437–446
Article
PubMed
PubMed Central
Google Scholar
Singh NA et al (2022) Atypical Alzheimer’s disease phenotypes with normal or borderline PET biomarker profiles. J Neurol 269:6613–6626
Article
CAS
PubMed
Google Scholar
Stopschinski BE et al (2021) (2021) Anatomic survey of seeding in Alzheimer’s disease brains reveals unexpected patterns. Acta Neuropathol Commun. 9:164
Article
PubMed
PubMed Central
Google Scholar
Terry RD et al (1987) Senile dementia of the alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46:262–268
Article
CAS
PubMed
Google Scholar
Thal DR et al (2010) Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease. Acta Neuropathol 120:169–183
Article
CAS
PubMed
Google Scholar
Tiraboschi P et al (2004) Alzheimer disease without neocortical neurofibrillary tangles: ‘A second look.’ Neurology 62:1141–1147
Article
CAS
PubMed
Google Scholar
Toledo JB et al (2016) Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology. Acta Neuropathol 131:393–409
Article
CAS
PubMed
Google Scholar
Vermersch P, Frigard B, Delacourte A (1992) Mapping of neurofibrillary degeneration in Alzheimer’s disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol 85:48–54
Article
CAS
PubMed
Google Scholar
Vogel JW et al (2019) Data-driven approaches for tau-PET imaging biomarkers in Alzheimer’s disease. Hum Brain Mapp 40:638–651
Article
PubMed
Google Scholar
Vogt BA et al (1998) Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer’s disease. Exp Neurol 22:8–22
Article
Google Scholar